Literature DB >> 26909380

Comparison of the amyloid pore forming properties of rat and human Alzheimer's beta-amyloid peptide 1-42: Calcium imaging data.

Coralie Di Scala1, Nouara Yahi1, Alessandra Flores1, Sonia Boutemeur1, Nazim Kourdougli2, Henri Chahinian1, Jacques Fantini1.   

Abstract

The data here consists of calcium imaging of human neuroblastoma SH-SY5Y cells treated with the calcium-sensitive dye Fluo-4AM and then incubated with nanomolar concentrations of either human or rat Alzheimer's β-amyloid peptide Aβ1-42. These data are both of a qualitative (fluorescence micrographs) and semi-quantitative nature (estimation of intracellular calcium concentrations of cells probed by Aβ1-42 peptides vs. control untreated cells). Since rat Aβ1-42 differs from its human counterpart at only three amino acid positions, this comparative study is a good assessment of the specificity of the amyloid pore forming assay. The interpretation of this dataset is presented in the accompanying study "Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides" [1].

Entities:  

Year:  2016        PMID: 26909380      PMCID: PMC4735473          DOI: 10.1016/j.dib.2016.01.019

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data The data provides a comparative study of Ca2+ fluxes induced by human and rat forms of Aβ1-42 peptide. The comparison of the Ca2+ fluxes induced by human and rat Aβ1-42 peptides may be used as an internal reference to validate this assay for studying amyloid pore formation induced by any amyloid protein in living neural cells. Researchers interested in testing amyloid pore formation and inhibitors of amyloid pores might carefully choose positive and negative controls with calibrated compounds.

Data

Amyloid pores [1], [2], [3], [4] are responsible for a dramatic increase of intracellular Ca2+ levels in brain cells that can be measured by fluorescence microscopic imaging [5], [6], [7], [8], [9], [10], [11], [12]. The dataset presented here contains the values of intracellular Ca2+ concentrations induced by human and rat Aβ1-42 peptides in neural SH-SY5Y cells. Amino acid sequence alignments of these peptides are presented in Fig. 1. Quantitative data (histograms) are given in Fig. 1, and fluorescence micrographs are shown in Fig. 2.
Fig. 1

Ca2+ fluxes induced by human and rat Aβ1-42 peptides in SH-SY5Y cells: a comparative study. Amino acid sequence alignments (upper panel) show that human and rat Aβ1-42 peptides differ at only three positions, all located in the ganglioside-binding domain (GBD) [1], [12]. SH-SY5Y cells treated with the calcium dye Fluo-4AM were incubated with human Aβ1-42 (blue histogram, n=87) or rat Aβ1-42 (red histogram, n=120) and calcium-dependent fluorescence was recorded after 60 min of incubation with the indicated peptides (lower panel). Results are expressed as mean±SEM. Statistical significance between human and rat Aβ1-42 (p=2.75×10−11) was evaluated by using Student׳s t-test.

Fig. 2

Cell imaging of Ca2+ fluxes induced by human and rat Aβ1-42 peptides in SH-SY5Y cells: a comparative study. The images show pseudocolor representations of cells (scale bar: 100 µm), warmer colors corresponding to higher fluorescence. The photographs are taken after 60 min of incubation with each peptide (same experimental conditions as in Fig. 1).

Experimental design, materials and methods

Materials

SH-SY5Y cells were obtained from ATCC. Dulbecco׳s Modified Eagle Medium: Nutrient Mixture F12 (DMEM/F12), HBSS, glutamine and penicillin/streptomycin were furnished by Gibco. Fluo-4AM was from Invitrogen. Human and rat Aβ1-42 peptides were purchased from rPeptide. The purity of these peptides was >95% as assessed by HPLC.

Cell culture

SH-SY5Y cells were cultured in DMEM/F12 supplemented with 10% fetal calf serum, glutamine (2 mM) and penicillin (50 U/mL)/streptomycin (50 µg/mL) and maintained at 37 °C with 5% CO2. Cells were passaged twice a week and not used beyond passage 25.

Calcium measurements

SH-SY5Y cells were plated (45.000 cells/dish) in 35 mm culture dishes and grown during 72 h at 37 °C. They were loaded with 5 µM Fluo-4AM for 30 min in the dark as previously described [1], [5]. The calcium fluxes were estimated by measuring the variation of cell fluorescence intensity after the injection of either rat or human Aβ1-42 (220 nM) into the recording chamber directly above an upright microscope objective (BX51W Olympus) equipped with an illuminator system MT20 module. Fluorescence emission at 525 nm was imaged by a digital camera CDD (Hamanatsu ORCA-ER) after fluorescence excitation at 490 nm. Time-lapse images (1 frame/10 s) were collected using the CellR Software (Olympus). Fluorescence intensity were measured from region of interest (ROI) centered on individual cells. Signals were expressed as fluorescence after treatment (Ft60) divided by the fluorescence before treatment (F0) and multiplied by 100. The results were averaged and the fluorescence of control is subtracted of each value. The experiments were performed at 30 °C during 60 min. In the pseudocolor representations of cells, warmer colors correspond to higher fluorescence and thus to higher Ca2+ levels.

Statistical analysis

Quantitative data are expressed as mean±S.E.M. and the statistical significance was assessed with the Student׳s t-test.
Subject areaNeurosciences
More specific subject areaMolecular basis of neurodegenerative diseases
Type of dataText file and figures
How data was acquiredFluorescent microscope
Data formatAnalyzed
Experimental factorsCells treated with the calcium-sensitive dye Fluo-4AM and then incubated with either human or rat Aβ1-42 peptide.
Experimental featuresControl cells are preloaded with Fluo-4AM and then treated with buffer alone to determine background intracellular calcium levels. This background is subtracted from the values induced by either human or rat Aβ1-42.
Data source locationNot applicable
Data accessibilityAll data are presented in this article
  11 in total

1.  Amyloid ion channels: a common structural link for protein-misfolding disease.

Authors:  Arjan Quist; Ivo Doudevski; Hai Lin; Rushana Azimova; Douglas Ng; Blas Frangione; Bruce Kagan; Jorge Ghiso; Ratnesh Lal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

2.  Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides.

Authors:  Jacques Fantini; Coralie Di Scala; Nouara Yahi; Jean-Denis Troadec; Kevin Sadelli; Henri Chahinian; Nicolas Garmy
Journal:  ACS Chem Neurosci       Date:  2014-01-12       Impact factor: 4.418

3.  Amyloid beta protein-(1-42) forms calcium-permeable, Zn2+-sensitive channel.

Authors:  S K Rhee; A P Quist; R Lal
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

4.  Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

Authors:  H Lin; R Bhatia; R Lal
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

Review 5.  Disruption of calcium homeostasis in the pathogenesis of Alzheimer's disease and other conformational diseases.

Authors:  Masahiro Kawahara
Journal:  Curr Alzheimer Res       Date:  2004-05       Impact factor: 3.498

6.  Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain.

Authors:  Cristian A Lasagna-Reeves; Charles G Glabe; Rakez Kayed
Journal:  J Biol Chem       Date:  2011-04-20       Impact factor: 5.157

7.  Neurodegenerative disease: amyloid pores from pathogenic mutations.

Authors:  Hilal A Lashuel; Dean Hartley; Benjamin M Petre; Thomas Walz; Peter T Lansbury
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

8.  Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.

Authors:  Coralie Di Scala; Nouara Yahi; Alessandra Flores; Sonia Boutemeur; Nazim Kourdougli; Henri Chahinian; Jacques Fantini
Journal:  Biochim Biophys Acta       Date:  2015-12-02

Review 9.  Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.

Authors:  Coralie Di Scala; Henri Chahinian; Nouara Yahi; Nicolas Garmy; Jacques Fantini
Journal:  Biochemistry       Date:  2014-07-11       Impact factor: 3.162

10.  Mechanism of cholesterol-assisted oligomeric channel formation by a short Alzheimer β-amyloid peptide.

Authors:  Coralie Di Scala; Jean-Denis Troadec; Clément Lelièvre; Nicolas Garmy; Jacques Fantini; Henri Chahinian
Journal:  J Neurochem       Date:  2013-08-28       Impact factor: 5.372

View more
  3 in total

Review 1.  Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Authors:  Jacques Fantini; Henri Chahinian; Nouara Yahi
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

2.  Pore Formation Mechanism of A-Beta Peptide on the Fluid Membrane: A Combined Coarse-Grained and All-Atomic Model.

Authors:  Yuxi Dai; Zhexing Xie; Lijun Liang
Journal:  Molecules       Date:  2022-06-18       Impact factor: 4.927

3.  Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells.

Authors:  Assou El-Battari; Léa Rodriguez; Henri Chahinian; Olivier Delézay; Jacques Fantini; Nouara Yahi; Coralie Di Scala
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.